This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Smith-McCune, K. Articles by Arbeit, J. Search for Related Content PubMed PubMed Citation Articles by Smith-McCune, K. Articles by Arbeit, J.

Cross-Species Comparison of Angiogenesis during the Premalignant Stages of Squamous Carcinogenesis in the Human Cervix and K14-HPV16 Transgenic Mice¹

Reproductive Endocrinology Center and Department of Obstetrics, Gynecology, and Reproductive Sciences, Box 0546 [K. S-M., Y-H. Z.], Hormone Research Institute, Box 0534 [D. H., J. A.], Department of Biochemistry and Biophysics [D. H.], and Department of Surgery [J. A.], University of California at San Francisco, San Francisco, California 94143

Infection of the human cervix with certain papillomavirus subtypes is associated with the development of neoplastic squamous lesions that can progress to overt cervical malignancies. Recently, multistage squamous carcinogenesis has been achieved in K14-HPV16 transgenic mice, wherein expression of the human papillomavirus (HPV) type 16 early genes is targeted to basal squamous epithelial cells by regulatory elements of the human keratin-14 (K14) promoter. Immunostaining of the endothelial marker vWf revealed a parallel upregulation of angiogenesis during the early neoplastic stages in both human cervix and the epidermis of K14-HPV16 transgenic mice. Moreover, high-grade premalignant lesions and cancers in humans and transgenic mice were characterized by an additional increment in the number of new capillaries and close apposition of the microvasculature to the overlying neoplastic epithelium. Expression of the potent angiogenic factor VEGF was progressively up-regulated during carcinogenesis in both species, correlating with the increased density and altered distribution of the microvasculature. Thus, angiogenesis occurs during the premalignant stages of squamous carcinogenesis in both human cervical disease and a relevant transgenic model and may be controlled by similar molecular mechanisms in both species. These results validate the use of the transgenic model to elucidate the role of angiogenesis during HPV-associated neoplastic progression.

¹ K. S-M. acknowledges the support of the Irwin Foundation, a grant from the National Cancer Institute, and the past support of the Reproductive Scientist Development Program (NICHD) and the American Gynecological and Obstetrical Society. Support for J. M. A. was from grants from the American Cancer Society and the Simon Fund of the University of California at San Francisco. The work performed in the Hanahan laboratory was supported by grants to the National Cancer Institute, including one to D. H. and a second to J. F. and D. H.

² To whom requests for reprints should be addressed, at Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California at San Francisco, San Francisco, CA 94143-0546.

Received 10/25/96. Accepted 2/ 8/97.

This article has been cited by other articles:

				A. Eichten, W. C. Hyun, and L. M. Coussens Distinctive Features of Angiogenesis and Lymphangiogenesis Determine Their Functionality during De novo Tumor Development Cancer Res., June 1, 2007; 67(11): 5211 - 5220. [Abstract] [Full Text] [PDF]

				X. Tang, Q. Zhang, J. Nishitani, J. Brown, S. Shi, and A. D. Le Overexpression of Human Papillomavirus Type 16 Oncoproteins Enhances Hypoxia-Inducible Factor 1{alpha} Protein Accumulation and Vascular Endothelial Growth Factor Expression in Human Cervical Carcinoma Cells Clin. Cancer Res., May 1, 2007; 13(9): 2568 - 2576. [Abstract] [Full Text] [PDF]

				M Branca, C Giorgi, D Santini, L Di Bonito, M Ciotti, A Benedetto, P Paba, S Costa, D Bonifacio, P Di Bonito, et al. Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer J. Clin. Pathol., January 1, 2006; 59(1): 40 - 47. [Abstract] [Full Text] [PDF]

				L. M. Brubaker, E. Bullitt, C. Yin, T. Van Dyke, and W. Lin Magnetic Resonance Angiography Visualization of Abnormal Tumor Vasculature in Genetically Engineered Mice Cancer Res., September 15, 2005; 65(18): 8218 - 8223. [Abstract] [Full Text] [PDF]

				S. Smola-Hess, J. Pahne, C. Mauch, P. Zigrino, H. Smola, and H. J. Pfister Expression of membrane type 1 matrix metalloproteinase in papillomavirus-positive cells: role of the human papillomavirus (HPV) 16 and HPV8 E7 gene products J. Gen. Virol., May 1, 2005; 86(5): 1291 - 1296. [Abstract] [Full Text] [PDF]

				D. Daniel, C. Chiu, E. Giraudo, M. Inoue, L. A. Mizzen, N. R. Chu, and D. Hanahan CD4+ T Cell-Mediated Antigen-Specific Immunotherapy in a Mouse Model of Cervical Cancer Cancer Res., March 1, 2005; 65(5): 2018 - 2025. [Abstract] [Full Text] [PDF]

				A. Sugiyama, Y. Miyagi, Y. Komiya, N. Kurabe, C. Kitanaka, N. Kato, Y. Nagashima, Y. Kuchino, and F. Tashiro Forced expression of antisense 14-3-3{beta} RNA suppresses tumor cell growth in vitro and in vivo Carcinogenesis, September 1, 2003; 24(9): 1549 - 1559. [Abstract] [Full Text] [PDF]

				V. Nayha, J. Laitakari, and F. Stenback Stage-Dependent Expression of an Angiogenic Agent and Vascular Organization in Experimental Skin Tumor Development Toxicol Pathol, August 1, 2003; 31(5): 539 - 548. [Abstract] [PDF]

				D. Daniel, N. Meyer-Morse, E. K. Bergsland, K. Dehne, L. M. Coussens, and D. Hanahan Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells J. Exp. Med., April 21, 2003; 197(8): 1017 - 1028. [Abstract] [Full Text] [PDF]

				D. A. Elson, H. E. Ryan, J. W. Snow, R. Johnson, and J. M. Arbeit Coordinate Up-Regulation of Hypoxia Inducible Factor (HIF)-1{{alpha}} and HIF-1 Target Genes during Multi-Stage Epidermal Carcinogenesis and Wound Healing Cancer Res., November 1, 2000; 60(21): 6189 - 6195. [Abstract] [Full Text]

				D. A. Elson, R. R. Riley, A. Lacey, G. Thordarson, F. J. Talamantes, and J. M. Arbeit Sensitivity of the Cervical Transformation Zone to Estrogen-induced Squamous Carcinogenesis Cancer Res., March 1, 2000; 60(5): 1267 - 1275. [Abstract] [Full Text]

				J. M. Arbeit, R. R. Riley, B. Huey, C. Porter, G. Kelloff, R. Lubet, J. M. Ward, and D. Pinkel Difluoromethylornithine Chemoprevention of Epidermal Carcinogenesis in K14-HPV16 Transgenic Mice Cancer Res., August 1, 1999; 59(15): 3610 - 3620. [Abstract] [Full Text] [PDF]

				J. A. Taylor, K. Tewari, S. Y. Liao, C. C. W. Hughes, and L. P. Villarreal Immunohistochemical Analysis, Human Papillomavirus DNA Detection, Hormonal Manipulation, and Exogenous Gene Expression of Normal and Dysplastic Human Cervical Epithelium in Severe Combined Immunodeficiency Mice J. Virol., June 1, 1999; 73(6): 5144 - 5148. [Abstract] [Full Text]

				L. M. Coussens, W. W. Raymond, G. Bergers, M. Laig-Webster, O. Behrendtsen, Z. Werb, G. H. Caughey, and D. Hanahan Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis Genes & Dev., June 1, 1999; 13(11): 1382 - 1397. [Abstract] [Full Text]